Who funds leukemia research?

We count 71 funded leukemia projects, active between 2020 and 2032, from 5 funders. The most came from EU · ERC (30 projects), NIH · NCI (12 projects) and EU · MSCA (10 projects). The median award is $2.1M, across the 66 of 71 projects that list an amount.

Funded projects

71

Funders

5

Median award

$2.1M

Open calls now

0

Top funders of leukemia research

Projects whose title or summary mentions leukemia. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open leukemia funding calls

No open call mentions leukemia in our listings today. We add new calls twice a day; create a free account to get an alert when one opens.

Funded leukemia projects

A sample, latest start first, at most three per program.

• COG NCTN Network Group Operations Center
  NIH · NCI · $28,393,333 · ends 2032
• Children's Oncology Group Statistics and Data Center
  NIH · NCI · $11,113,171 · ends 2032
• Development of next-generation CAR-T cells for enhanced efficacy and reduced toxicity in T-cell acute lymphoblastic leukaemia (T-ALL)
  Wellcome · £1,283,786 · ends 2031
• The Memorial Sloan Kettering Cancer Center SPORE in Leukemia
  NIH · NCI · $3,031,373 · ends 2031
• A longitudinal multi-omic approach to understanding the evolution of myelodysplastic syndrome (MDS) and the factors that drive or impede clonal evolution towards acute myeloid leukaemia (AML)
  Wellcome · £1,091,988 · ends 2029
• SBIR Phase II: Antibody Therapy that Targets Neoantigens in Acute Myeloid Leukemia by Leveraging Both Innate and Adaptive Immune Mechanisms
  NSF · TIP · $1,244,469 · ends 2028
• Investigating the role of the Dnmt3a R882H mutation in subverting normal haematopoiesis and in malignant transformation
  Wellcome · ends 2028
• Dissecting the role of pathologically co-opted HIF-1 within aberrant RNA-splicing driving malignant haematopoiesis
  UKRI · MRC · £725,818 · ends 2028
• Decoding the immuno-regulatory functions of the human bone marrow niche upon cancer cellular therapy
  EU · ERC · €2,000,000 · 2027–2032 · LUNDS UNIVERSITET
• Understanding how the host immunity, the microbiome and environmental stressors shape the ecology and evolution of horizontal transmissible cancers in marine bivalves.
  EU · ERC · €2,006,562 · 2027–2032 · MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “leukemia or leukaemia”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.